Skip to main content

Table 3 Virologic, Biochemical Variables of Patients at 24 weeks After Treatment

From: Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial

Variable CIFN group
(n = 72)
IFN-alpha group
(n = 70)
ALT normalization, n (%) 38 (52.8) 37 (52.9)
Loss of HBV-DNA, n (%) 17 (23.6) 14 (20.0)
HBeAg/anti-HBe seroconversion, n (%) 12 (16.7) 12 (17.1)
Loss of HbeAg, n (%) 11 (15.3) 10 (14.3)
Complete response, n (%) 5 (6.9) 5 (7.1)
Partial response, n (%) 27 (37.5) 24 (34.3)
  1. CIFN, consensus interferon; IFN, interferon